Cardiac Dimensions Revenue and Competitors

Seattle, WA USA

Location

#4911

Growjo Ranking

Estimated Revenue & Valuation

  • Cardiac Dimensions's estimated annual revenue is currently $8.5M per year.(i)
  • Cardiac Dimensions's estimated revenue per employee is $125,500
  • Cardiac Dimensions's total funding is $208M.

Employee Data

  • Cardiac Dimensions has 68 Employees.(i)
  • Cardiac Dimensions grew their employee count by 5% last year.

Cardiac Dimensions's People

NameTitleEmail/Phone
1
Vice Pres. R.&D.Reveal Email/Phone
2
VP, Operations and ComplianceReveal Email/Phone
3
VP SalesReveal Email/Phone
4
VP, ClinicalReveal Email/Phone
5
Chief Clinical OfficerReveal Email/Phone
6
Director ManufacturingReveal Email/Phone
7
Director, QA and Regulatory AffairsReveal Email/Phone
8
Director TechnologyReveal Email/Phone
9
Director Quality Assurance and Regulatory AffairsReveal Email/Phone
10
Director, Therapy DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M39117%$14.9MN/A
#2
$44.9M143-30%$211.3MN/A
#3
$54M17211%$35.5MN/A
#4
$4.3M17-19%N/AN/A
#5
$18.3M73N/AN/AN/A
#6
$8.3M336%N/AN/A
#7
$81.1M32317%N/AN/A
#8
$7M28-12%N/AN/A
#9
$204.8M8163%N/AN/A
#10
$6.3M5025%$27.5MN/A
Add Company

What Is Cardiac Dimensions?

Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of congestive heart failure ("CHF") and related conditions. CHF is a life-threatening condition afflicting nearly 5 million Americans and responsible for 2.5 million hospital admissions each year. Given their poor state of health, CHF patients are rarely candidates for conventional surgical procedures that could extend and improve their lives. Cardiac Dimensions is developing minimally invasive therapies as an alternative to surgery, thus significantly expanding the pool of CHF patients that can be helped. Cardiac Dimensions, based in Seattle, Washington was founded in 2001 by Scout Medical Technologies, and is funded by leading venture capital firms MPM Capital, Polaris Venture Partners and InterWest Partners.

keywords:Biotechnology, Healthcare, Medical Devices

$208M

Total Funding

68

Number of Employees

$8.5M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cardiac Dimensions News

2022-04-17 - Bookings to open next week for heart screening event

An echocardiogram ultrasound scan will also be carried out. This measures cardiac dimensions and the flow of blood in and out of the heart.

2022-04-13 - Childhood cardiovascular morphology and function following abnormal fetal growth

We studied the effect of abnormal fetal growth on cardiac morphology ... effect of fetal programming on cardiac dimensions during childhood.

2020-10-01 - Seattle-area startup Cardiac Dimensions raises $17.5M for heart-valve repair device

Kirkland, Wash.-based Cardiac Dimensions raised a $17.5 million Series C round. The company will use the fresh cash to help sell its heart-valve repair device. Founded in 2001, the Seattle-area medical device startup has developed a way to address cardiovascular conditions with its Carillon Mit ...

2020-09-30 - Cardiac Dimensions Raises $17.5M in Series C Financing

Cardiac Dimensions, a Kirkland, Wash.-based leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, closed a $17.5m Series C financing. All existing shareholders participated in the round including Aperture ...

2018-04-26 - Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure

KIRKLAND, Wash.–(BUSINESS WIRE)– Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with heart failure, today announced the company has closed a $39 million Series B financing. The round includes new investor, Australia-based Hostplus, ventu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M706%N/A
#2
$15.9M7030%N/A
#3
$8.2M70-18%N/A
#4
$13.4M7129%N/A
#5
$16.5M720%N/A